Optimizing membrane repair for the treatment of duchenne muscular dystrophy
Ended Project Grant Awarded Last action
- Award ID
- R41AR076276
- Recipient
-
Myofinity Biosciences Inc. UEI JF5CJQH8NNH1
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $150,378
Award facts
- Assistance listing
- 93.846 Arthritis, Musculoskeletal and Skin Diseases Research
- Completion date
- Funding
-
- $175,189.00 Federal
- -$24,811.00 Non-federal
- Place of performance
- Boston, MA 02111, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | -$24,811 | $0 | |
| Amendment | -$24,811 | -$24,811 | |
| Original award | $224,811 | $0 |
Quick answers
Who received award R41AR076276?
R41AR076276 was awarded to Myofinity Biosciences Inc. by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on September 17, 2019.
How much is award R41AR076276 worth?
$150,378 has been obligated on R41AR076276: $175,189 in federal funding and -$24,811 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award